Multidrug efflux in Gram-negative bacteria: structural modifications in active compounds leading to efflux pump...

Area of Science:

• Microbiology
• Drug Discovery
• Computational Chemistry

Background:

• Gram-negative bacteria are responsible for most drug-resistant infections.
• Developing new antibiotics is critical, but challenging due to bacterial defense mechanisms.
• Efflux pumps in Gram-negative bacteria actively remove drugs, limiting treatment efficacy.

Purpose of the Study:

• To identify molecular features that enable compounds to evade recognition by Gram-negative bacterial efflux pumps.
• To understand the principles governing compound interaction with efflux systems, specifically TolC in E. coli.
• To guide the design of new antimicrobial agents effective against Gram-negative pathogens.

Main Methods:

• Quantitative analysis of 73,737 compounds from the CO-ADD database against three E. coli strains (wild-type, tolC, lpxC).
• Computational investigation of molecular descriptors influencing recognition by TolC-dependent efflux pumps.
• Comparative analysis of efflux pump evasion with inward permeability data.

Main Results:

• Specific physicochemical properties and the presence/absence of certain chemical groups significantly impact a compound's ability to avoid efflux.
• TolC efflux pumps play a major role in determining drug bioactivity in Gram-negative bacteria.
• Identified key molecular determinants for evading efflux pump recognition.

Conclusions:

• Drug efflux is a primary barrier to antibiotic efficacy in Gram-negative bacteria.
• Targeting molecular features that evade efflux pumps can enhance drug design strategies.
• This research provides a foundation for developing novel therapeutics against drug-resistant Gram-negative infections.